Suicide and Trauma Reduction Initiative Among VEterans
STRIVE
1 other identifier
interventional
45
1 country
1
Brief Summary
The present study is a pragmatic clinical trial that will examine the effectiveness of Cognitive Processing Therapy (CPT) in reducing PTSD symptom severity, depression symptoms, and suicidal thoughts among military personnel and veterans with PTSD when delivered in three different formats: (1)12 sessions delivered once per week in an office/clinic setting; (2) 12 sessions delivered once per day in an office/clinic setting; and (3) 12 sessions delivered once per day in a recreational setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 21, 2019
CompletedFirst Submitted
Initial submission to the registry
April 18, 2019
CompletedFirst Posted
Study publicly available on registry
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMarch 4, 2025
May 1, 2023
3.8 years
April 18, 2019
February 27, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in PTSD symptom severity since baseline measured by the Clinician Administered PTSD Scale
Interviewer administered measure to determine the severity of PTSD. Items are summed to create a total score (Range: 0-80) where higher scores indicate greater symptom severity.
Past month symptoms, assessed within a month of completing treatment, and 6-months, 12-months, 18-months, and 24 months after completing treatment
Change in PTSD symptom severity since baseline measured by the Clinician Administered PTSD Scale
Interviewer administered measure to determine the severity of PTSD. Items are summed to create a total score (Range: 0-80) where higher scores indicate greater symptom severity.
Past week symptoms, assessed the last day of treatment for those completing the two week treatment retreats
Secondary Outcomes (2)
Change in suicidal thoughts and behaviors since baseline measured by the Scale for Suicidal Ideation
Past week symptoms, assessed within a month of completing treatment, and 6-months, 12-months, 18-months, and 24 months after completing treatment
Change in depression symptom severity since baseline measured by the Patient Health Questionnaire
Past two week symptoms, assessed within a month of completing treatment, and 6-months, 12-months, 18-months, and 24 months after completing treatment
Study Arms (3)
R&R Park City, Utah
ACTIVE COMPARATORThis group will receive 12 daily individual sessions of CPT at the National Ability Center in Park City, Utah. They will also participate in daily recreational activities.
R&R Salt Lake City, Utah
ACTIVE COMPARATORThis group will receive 12 daily individual sessions of CPT at the National Center for Veterans Studies located on the University of Utah campus in Salt Lake City, Utah.
Weekly Treatment Salt Lake City, Utah
ACTIVE COMPARATORThis group will receive 12 individual sessions of CPT on a weekly basis at the National Center for Veterans Studies located on the University of Utah campus in Salt Lake City, Utah.
Interventions
Cognitive Processing Therapy is a primarily cognitive form of Cognitive Behavioral Therapy, which has been shown to be effective at reducing symptoms of PTSD.
Eligibility Criteria
You may qualify if:
- years of age or older;
- Current or prior service in the U.S. military;
- Currently meet criteria for a diagnosis of posttraumatic stress disorder (as determined by the CAPS-5);
- Be able to complete the informed consent process.
You may not qualify if:
- Current substance dependence disorder;
- Severe suicide ideation during the past two weeks (as determined by the BSSI and clinical interview) warranting hospitalization;
- Suicide attempt during the previous three months;
- Impaired mental status that precludes ability to provide informed consent (e.g., intoxication, psychosis, mania).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- The Boeing Companycollaborator
Study Sites (1)
University of Utah
Salt Lake City, Utah, 84112, United States
Related Publications (1)
Bryan CJ, Leifker FR, Rozek DC, Bryan AO, Reynolds ML, Oakey DN, Roberge E. Examining the effectiveness of an intensive, 2-week treatment program for military personnel and veterans with PTSD: Results of a pilot, open-label, prospective cohort trial. J Clin Psychol. 2018 Dec;74(12):2070-2081. doi: 10.1002/jclp.22651. Epub 2018 Jun 19.
PMID: 29917224BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2019
First Posted
May 1, 2019
Study Start
March 21, 2019
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
March 4, 2025
Record last verified: 2023-05